Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, Nanshan Zhong, Tianxiang Zhang et al.|EClinicalMedicine|2024Cited by 23
Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysisShanbing Hou, Min Dou, Yuqing Wang et al.|BMC Endocrine Disorders|2025Cited by 3
Correction: Cardiac metabolic index as a predictor of new-onset diabetes in non-alcoholic fatty liver disease patients: a longitudinal cohort analysisShanbing Hou, Min Dou, Yuqing Wang et al.|BMC Endocrine Disorders|2025Cited by 2